Static Chart StemRIM

Stocks

Market Closed - Japan Exchange 06:30:00 28/10/2026 GMT			5-day change	1st Jan Change
147.00 ^JPY	+2.80%		-4.55%	-44.11%

10-07	StemRIM Inc. Announces Patent Registration for Stem Cell Gene Therapy Technology SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in USA	CI
09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI

Duration

Period